BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 12417722)

  • 1. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
    Law BK; Chytil A; Dumont N; Hamilton EG; Waltner-Law ME; Aakre ME; Covington C; Moses HL
    Mol Cell Biol; 2002 Dec; 22(23):8184-98. PubMed ID: 12417722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein.
    Brown KA; Roberts RL; Arteaga CL; Law BK
    Breast Cancer Res; 2004; 6(2):R130-9. PubMed ID: 14979923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
    Tyagi A; Agarwal C; Agarwal R
    Cell Cycle; 2002; 1(2):137-42. PubMed ID: 12429923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
    Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
    Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.
    Smith E; Redman RA; Logg CR; Coetzee GA; Kasahara N; Frenkel B
    J Biol Chem; 2000 Jun; 275(26):19992-20001. PubMed ID: 10867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS; Prall OW; Musgrove EA; Sutherland RL
    J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
    Woo MS; Sánchez I; Dynlacht BD
    Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased growth inhibitory responses of squamous carcinoma cells to interferon-gamma involve failure to recruit cki proteins into cdk2 complexes.
    Harvat BL; Jetten AM
    J Invest Dermatol; 2001 Nov; 117(5):1274-81. PubMed ID: 11710944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.
    Tedesco D; Baron L; Fischer-Fantuzzi L; Vesco C
    J Virol; 1997 Mar; 71(3):2217-24. PubMed ID: 9032356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
    Hu X; Zuckerman KS
    Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest.
    Donovan JC; Rothenstein JM; Slingerland JM
    J Biol Chem; 2002 Nov; 277(44):41686-92. PubMed ID: 12202478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
    Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
    Dhillon NK; Mudryj M
    Oncogene; 2002 Jul; 21(30):4626-34. PubMed ID: 12096339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.